Applying Molecular Testing in Practice with Case Discussions and Expert Panel

Join the Association for Molecular Pathology for a live webinar at 2 pm ET on October 30, during which Karthik Giridhar will illustrate how advances in molecular testing are transforming how oncologists approach metastatic HR+/HER2- breast cancer. This session features real-world patient stories that highlight how specific genomic alterations—like PIK3CA and ESR1 variants—can guide personalized treatment strategies and improve outcomes. Following the case discussions, a panel with the Metastatic Brest Cancer Webinar Series Working Group members will dive deeper into the challenges and opportunities of integrating biomarker data into clinical practice, offering an interactive dialogue and live Q&A with the audience. Together, they’ll explore how precision oncology is reshaping decision-making and collaboration in cancer care.

This is part three in a three-part series about molecular genetic testing methods and current best practices for HR+/HER2- breast cancer.

Register for the webinar: https://educate.amp.org/local/catalog/view/product.php?productid=577